CStone Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	457.77	387.94	996.67	558.68	742.72	3,025
Short-Term Investments	232.34	331.95	51.85	588.91	913.07	536.91
Trading Asset Securities	-	-	-	-	122.9	10.13
Cash & Short-Term Investments	690.1	719.88	1,049	1,148	1,779	3,572
Cash Growth	-19.54%	-31.34%	-8.63%	-35.48%	-50.20%	23.75%
Accounts Receivable	62.54	83.93	172.44	77.13	117.6	-
Receivables	62.54	83.93	172.44	77.13	117.6	-
Inventory	148.85	286.1	108.83	22.19	61.36	-
Other Current Assets	-	-	-	-	-	0.72
Total Current Assets	901.49	1,090	1,330	1,247	1,958	3,572
Property, Plant & Equipment	109.99	130.54	153.37	206.57	182.8	66.54
Long-Term Investments	4.85	9.03	3.54	3.48	3.19	-
Other Intangible Assets	155.53	161.37	173.05	159.7	70.54	6.51
Other Long-Term Assets	20.06	2.62	2.26	21.76	57.28	117.4
Total Assets	1,192	1,393	1,662	1,638	2,271	3,763
Accounts Payable	212.09	338.03	246.38	290.41	414.29	28.03
Accrued Expenses	145.08	195.23	372.28	400.87	400.65	551.19
Current Portion of Long-Term Debt	194	60.8	105.99	8.57	30.7	2.66
Current Portion of Leases	25.95	32.42	33.33	36.35	13.25	8.65
Current Income Taxes Payable	1.43	1.77	17.66	5.82	24.29	6.09
Current Unearned Revenue	10.39	10.39	6.89	7	7.45	7.21
Other Current Liabilities	36.88	43.37	67.82	197.46	42.31	123.21
Total Current Liabilities	625.8	682.01	850.34	946.48	932.95	727.05
Long-Term Debt	169.2	257.4	213	218.99	115.81	54.34
Long-Term Leases	2.23	5.36	11.14	22.39	14.44	18.21
Long-Term Unearned Revenue	79.64	84.83	61.97	1.25	1.25	8.7
Other Long-Term Liabilities	-	-	68.73	-	-	-
Total Liabilities	876.86	1,030	1,205	1,189	1,064	808.29
Common Stock	0.92	0.86	0.86	0.8	0.8	0.79
Additional Paid-In Capital	9,229	9,004	8,992	8,628	8,465	8,324
Retained Earnings	-9,381	-9,111	-9,020	-8,652	-7,750	-5,830
Treasury Stock	-0	-0.01	-0.01	-0	-0.01	-0.02
Comprehensive Income & Other	466.72	469.99	483.25	473.09	491.44	459.09
Total Common Equity	315.04	363.87	456.83	449.33	1,207	2,954
Shareholders' Equity	315.04	363.87	456.83	449.33	1,207	2,954
Total Liabilities & Equity	1,192	1,393	1,662	1,638	2,271	3,763
Total Debt	391.37	355.97	363.45	286.29	174.2	83.86
Net Cash (Debt)	298.73	363.91	685.07	861.31	1,604	3,488
Net Cash Growth	-42.88%	-46.88%	-20.46%	-46.32%	-54.00%	21.02%
Net Cash Per Share	0.23	0.29	0.54	0.73	1.38	3.33
Filing Date Shares Outstanding	1,361	1,277	1,275	1,198	1,173	1,147
Total Common Shares Outstanding	1,361	1,277	1,275	1,198	1,173	1,147
Working Capital	275.69	407.9	479.45	300.44	1,025	2,845
Book Value Per Share	0.23	0.28	0.36	0.38	1.03	2.58
Tangible Book Value	159.52	202.51	283.79	289.63	1,136	2,948
Tangible Book Value Per Share	0.12	0.16	0.22	0.24	0.97	2.57
Machinery	-	13.79	14.11	19.1	18.95	16.57
Construction In Progress	-	151.75	151.75	151.76	138.67	21.48
Leasehold Improvements	-	21.28	21.28	21.28	20.31	19.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.